BioHive Summit Recap
November 12, 2022
On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants.
Governor Cox welcomed attendees during the morning plenary session, stressing the importance of Utah’s life sciences industry which generates more GDP for the state than tourism. Dr. “Jeff” Shuren zoomed in for a town hall taking live questions from the audience on a variety of topics. Kelvyn Cullimore was chided for not referring to Dr. Shuren as “Jeff” – nice to be on a first name basis!
Katie Peng, chief commercial officer of Denali Therapeutics gave a very personal perspective of healthcare systems. Dr. Lincoln Nadauld, CEO of Culmination Bio talked about his journey in precision medicine and genomics and how this technology will direct better healthcare in the future.
The morning concluded with a fireside chat with Cullimore and experienced political observers, Jeff Kimbell of Jeffrey J. Kimbell and Associates, and Nick Shipley, chief advocacy officer for BIO who provided their perspectives on how the election outcomes could impact the life sciences industry.
Recent News
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
- Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial
- Myriad Genetics Announces RiskScore Study Published in JCO Precision Oncology